PROM1 and cancer: The Cox regression model revealed that the patients with a lower percentage CD133+ cells (<5%) in the cancer nests were significantly associated with a higher 5-year survival rate with -0.987 in partial regression coefficient and 0.373 (95% CI 0.190 ~ 0.732) in relative risk (P = 0.004).